Delivery Order SPE2DB20D3101-SPE2DB24FRVH2
Award Date
9/18/24
Potential Completion Date
9/19/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,567,745,478 units of the drug Lamotrigine ER 300 mg tablets. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 31, 2025. The contract has a ceiling value of $4,041.17 and runs through April 1, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,428.90 firm fixed-price delivery order contract is for the supply of 4567983871 - Lamotrigine ER 300 mg Tablets. The contract has an ultimate completion date of April 22, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of Lamotrigine ER 300 mg tablets to the U.S. government. The $1,004.29 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), under a broader Indefinite Delivery Contract (IDC) valued up to $999,999,999.00. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a...
The federal contract award is for the supply of the medication Lamotrigine ER 250 mg tablets to the Defense Logistics Agency (DLA). The $4,284.45 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 9, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,844.25 firm fixed-price delivery order is for the supply of Lamotrigine ER 300 mg tablets, a prescription anticonvulsant medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the...
This federal contract award, valued at $1,265.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of LAMOTRIGINE ER 100 MG TABLET 30S, a generic medication, with a performance period extending through March 24, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FQG95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567938003 LAMOTRIGINE ER 300 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,419.18 and a completion date of April 17, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This federal contract award, valued at $3,128.25, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lamotrigine ER 250 mg tablets, a pharmaceutical product used to treat certain mental health conditions. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. The contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,896.92 and runs through April 30, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order, valued at $1,995.26, is for the supply of Lamotrigine ER 250 mg tablets. The contract is a firm-fixed-price Delivery Order with an ultimate completion date of September 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...